Glucotrack to Participate in the Q3 Virtual Investor Summit [Yahoo! Finance]
GlucoTrack, Inc. (GCTK)
Company Research
Source: Yahoo! Finance
the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that management will present and participate in one-on-one meetings with investors at the Q3 Virtual Investor Summit, being held on September 16-17, 2025. Presentation details Presenter: Paul V. Goode, PhD, President and Chief Executive Officer Date: Tuesday, September 16, 2025 Time: 1:30PM ET Webcast Link: Investor Summit Group Q3 Virtual Conference / Glucotrack Investor registration: Investor Summit Group About Glucotrack, Inc. Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack's CBGM is a long-term, implantable system that continually measures blood glucose levels wit
Show less
Read more
Impact Snapshot
Event Time:
GCTK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GCTK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GCTK alerts
High impacting GlucoTrack, Inc. news events
Weekly update
A roundup of the hottest topics
GCTK
News
- Glucotrack, Inc. Encourages Shareholders to VoteGlobeNewswire
- Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory TeamGlobeNewswire
- Glucotrack, Inc. Reminds Shareholders to VoteGlobeNewswire
- Glucotrack to Participate in the Q3 Virtual Investor SummitGlobeNewswire
GCTK
Sec Filings
- 11/7/25 - Form DEFA14A
- 11/7/25 - Form 8-K
- 11/6/25 - Form 8-K
- GCTK's page on the SEC website